Medidata to Showcase Rave Omics with Biomarker Discovery in Oncology Research at Industry Expert Theater Presentation
May 21 2018 - 8:40AM
Business Wire
Integration of Genomic and Clinical Trial Data
Enables Biomarker Hypothesis Generation by Clinical Development
For the second consecutive year, Medidata (NASDAQ:MDSO) will be
presenting its pioneering analytics innovation during the 2018 ASCO
Annual Meeting. The hour-long “Industry Expert Theater” session*,
Integration of Genomics Data and Analysis in Oncology Research,
will occur on June 2 at 9:30 AM CDT at the Oncology Professionals
Hall, McCormick Place Convention Center in Chicago.
Medidata experts will showcase the value of Medidata Rave
Omics with Biomarker Discovery in Oncology:
- Expanding clinical development outcomes
from hypothesis confirmation to iterative hypothesis
generation.
- Streamlining data capture, linking, and
analysis within the clinical study process to sharpen genomic
insights and shorten drug development timelines.
- Applying machine learning and automated
statistical methodology at an accessible level.
- Uncovering novel insights:
including data quality concerns, genes linked to response and
adverse events, and novel patient clusters.
Speakers:
- Jason Mezey, PhD, Principal Researcher
for Rave Omics, Medidata Solutions; Professor, Cornell University
& Weill Cornell Medicine
- Ruthanna Davi, PhD, Sr. Director of
Data Science, Medidata Solutions; Former Deputy Director, Division
of Biometrics II, Office of Biostatistics, CDER, FDA
- Ana Oromendia, PhD, Business Analytics
Manager for Rave Omics, Medidata Solutions
About Medidata
Medidata's unified platform, pioneering analytics, and unrivaled
expertise power the development of new therapies for over 1,000
pharmaceutical companies, biotech, medical device firms, academic
medical centers and contract research organizations around the
world. The Medidata Clinical Cloud® connects patients, physicians
and life sciences professionals. Companies on the Medidata platform
are individually and collaboratively reinventing the way research
is done to create smarter, more precise treatments. For more
information: www.mdsol.com
*The “Industry Expert Theater Presentation” is a series of
hour-long presentations from industry leaders sharing the latest in
oncology practices, products, services and technologies. Not an
official presentation of the meeting. Not sponsored, endorsed, or
accredited by ASCO or the Conquer Cancer Foundation. Not
CME-accredited.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180521005554/en/
Investors:Medidata SolutionsBetsy Frank,
+1-917-522-4620bfrank@mdsol.comorMedia:Medidata SolutionsErik
Snider, +1-646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Sep 2023 to Sep 2024